Causes of Elevated Ammonia in Patients Without Cirrhosis
In patients without cirrhosis, elevated ammonia most commonly results from urea cycle disorders (particularly ornithine transcarbamylase deficiency), organic acidemias, drug toxicity (especially valproic acid), acute kidney injury, and infections—with prompt recognition being critical as levels >200 µmol/l can cause fatal cerebral edema. 1
Primary Metabolic Causes
Urea Cycle Disorders (UCDs)
The most frequent non-cirrhotic cause of hyperammonemia involves congenital deficiency of any of six enzymes in the urea cycle 1:
- N-acetylglutamate synthase (NAGS)
- Carbamoyl phosphate synthase I (CPS)
- Ornithine transcarbamylase (OTC) - the most common UCD, occurring in 1 in 56,500 births
- Argininosuccinate synthetase (ASS)
- Argininosuccinate lyase (ASL)
- Arginase 1
Critical pitfall: UCDs can present in adults with partial enzyme deficiencies that become symptomatic only during metabolic stress (infection, surgery, high protein intake, pregnancy). These late-onset presentations are frequently missed because clinicians don't consider inherited metabolic disorders in adults 2, 3.
Organic Acidemias
These occur in approximately 1 in 21,000 births and cause mild to moderate hyperammonemia through competitive inhibition of NAGS 1:
- Methylmalonic acidemia
- Propionic acidemia
- Isovaleric acidemia
- Multiple carboxylase deficiency
Secondary Causes
Drug-Induced Hyperammonemia
Valproic acid is the most important drug cause, inducing secondary inhibition of the urea cycle 1. Other medications can also precipitate hyperammonemia, particularly in patients with underlying partial enzyme deficiencies.
Acute Kidney Injury
Impaired renal excretion of ammonia and glutamine leads to accumulation, as the kidneys normally excrete a significant fraction of ammonia metabolism products 1.
Infections
Urea-splitting bacterial infections can elevate ammonia levels 3, 4.
Hypercapnia-Induced Hyperammonemia
A recently recognized phenomenon where severe hypercapnia causes transient hyperammonemia through altered pulmonary vascular dynamics and metabolic processes, even without liver disease 5. Key point: Ammonia should be rechecked after correcting hypercapnia to determine if elevation is transient.
Post-Transplant Complications
Hyperammonemia can occur following solid organ transplantation 6, 4.
Portosystemic Shunts
Congenital or acquired shunts can bypass hepatic ammonia metabolism 3.
Clinical Recognition Strategy
When to Suspect Non-Cirrhotic Hyperammonemia
Measure ammonia urgently in any patient with:
- Unexplained coma or altered mental status
- Respiratory alkalosis (from hyperventilation attempting to compensate)
- Neurological symptoms: confusion, lethargy, seizures, ataxia
- History of protein intolerance or avoidance
- Failure to thrive (in younger patients)
- Psychiatric manifestations: irritability, delusion, psychosis 1, 4
Diagnostic Thresholds
- Normal: ≤35 µmol/l (<60 µg/dl)
- Hyperammonemia in adults: ≥50 µmol/l (85 µg/dl)
- Poor neurological outcomes: >200 µmol/l (341 µg/dl)
- Life-threatening: Levels approaching 800 µg/dl have been reported 1, 2
Pathophysiology and Urgency
The danger lies in cerebral edema: Elevated ammonia is metabolized to glutamine by astrocytes, causing increased intracellular osmolality, extracellular potassium elevation, and inflammatory cytokine release, leading to neuronal damage 1. Unlike cirrhotic patients who may tolerate chronic elevations, acute severe hyperammonemia from non-hepatic causes can cause fatal cerebral edema rapidly 6, 4.
Management Principles
When hyperammonemia is confirmed without cirrhosis:
- Immediate neuroprotection: Prevent cerebral edema
- Short-term protein restriction with appropriate nutritional support
- Rapid ammonia removal: High-dose continuous renal replacement therapy is preferred for severe elevations 6, 7
- Ammonia scavengers: IV formulations (sodium benzoate, sodium phenylacetate) for acute management; oral for chronic control 3
- Treat underlying cause: Stop offending drugs, treat infections, correct metabolic derangements
Critical timing: Early intervention before ammonia exceeds 200 µmol/l significantly improves neurological outcomes and prevents irreversible brain injury 1, 6.